4C

Serial Number 88232534
Registration 5871682
700

Registration Progress

Application Filed
Dec 17, 2018
Under Examination
Approved for Publication
Apr 30, 2019
Published for Opposition
Jul 16, 2019
Registered
Oct 1, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-10-01)
Due: Oct 01, 2025 77 days

Trademark Image

4C

Basic Information

Serial Number
88232534
Registration Number
5871682
Filing Date
December 17, 2018
Registration Date
October 1, 2019
Published for Opposition
July 16, 2019
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 1, 2019
Registration
Registered
Classes
045

Rights Holder

4C Pharma Solutions LLC

16
Address
Suite 111
15 Corporate Place South
Piscataway, NJ 08854

Ownership History

4C Pharma Solutions LLC

Original Applicant
16
Piscataway, NJ

4C Pharma Solutions LLC

Owner at Publication
16
Piscataway, NJ

4C Pharma Solutions LLC

Original Registrant
16
Piscataway, NJ

Legal Representation

Attorney
Timothy X. Gibson

USPTO Deadlines

Next Deadline
77 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-10-01)
Due Date
October 01, 2025
Grace Period Ends
April 01, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

21 events
Date Code Type Description Documents
Oct 1, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Oct 1, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 16, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 16, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 26, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 13, 2019 ALIE A ASSIGNED TO LIE Loading...
May 30, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 30, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 30, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 30, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 30, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 30, 2019 ISSR Z WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST Loading...
May 30, 2019 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Apr 30, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 30, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 10, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 18, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 13, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 10, 2019 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jan 9, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 20, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 045
Regulatory compliance consulting in the field of prescription drug sampling; tracking and monitoring regulatory requirements in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics for regulatory compliance purposes; regulatory compliance consulting in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics
First Use Anywhere: Sep 8, 2018
First Use in Commerce: Sep 8, 2018

Additional Information

Design Mark
The mark consists of the characters "4" and "C" are adjacent one another, and four crescents of diminishing size when viewed from left to right are positioned with the open sides of the crescents at varying degrees about the character "4".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
FOUR C

Classification

International Classes
045